This inventor holds 1 USPTO granted patent and 7 published patent applications. Top assignee: Flagship Pioneering Innovations V, Inc.. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: Alexandra Lantermann: Innovator in Cancer Treatment
Introduction
Alexandra Lantermann is a prominent inventor based in Boston, MA (US). She has made significant contributions to the field of cancer treatment through her innovative research and development of new therapeutic methods.
Latest Patents
Lantermann holds 1 patent for her invention titled "Methods and compositions for treating cancer using P2RX2 inhibitors." This groundbreaking invention provides methods for treating cancer using P2RX2 inhibitors, including P2RX2 inhibitory antibodies. The patent also features compositions containing P2RX2 inhibitors, methods for diagnosing patients with P2RX2-associated cancer, and methods for predicting the response of cancer in a subject to treatment with P2RX2 inhibitors.
Career Highlights
Lantermann is currently associated with Flagship Pioneering Innovations V, Inc., where she continues to advance her research in cancer therapies. Her work is characterized by a commitment to improving patient outcomes through innovative treatment options.
Collaborations
Throughout her career, Lantermann has collaborated with notable colleagues, including Avak Kahvejian and Jordi Mata-Fink. These partnerships have further enhanced her research and development efforts in the field of cancer treatment.
Conclusion
Alexandra Lantermann is a dedicated inventor whose work in cancer treatment is paving the way for new therapeutic approaches. Her innovative methods and compositions are set to make a significant impact in the medical field.